Methylcobalamin + Pyridoxine Hydrochloride + Folic AcidThird Party Manufacturing in India

Methylcobalamin, Pyridoxine Hydrochloride, and Folic Acid is a rationally designed fixed-dose combination that addresses three interdependent pathways in homocysteine metabolism and neuronal health. Methylcobalamin, the active coenzyme form of vitamin B12, serves as a methyl group donor in the methionine synthase reaction, where it facilitates the conversion of homocysteine to methionine. This reaction requires simultaneous participation of 5-methyltetrahydrofolate, the active form of folic acid, which provides the methyl group that methylcobalamin transfers to homocysteine. Pyridoxine Hydrochloride, as the precursor of pyridoxal-5-phosphate, acts as an essential cofactor for cystathionine-beta-synthase, the enzyme that diverts homocysteine into the transsulfuration pathway for conversion to cysteine. By supporting both the remethylation and transsulfuration pathways, this triple combination creates a synergistic effect that more effectively lowers homocysteine levels than any single component. Elevated homocysteine is a recognized risk factor for neuropathy, cardiovascular disease, and cognitive decline. Additionally, methylcobalamin supports myelin sheath synthesis and regeneration in peripheral nerves, while folic acid provides the one-carbon units essential for DNA synthesis and repair in rapidly dividing cells.

Therapeutic Uses

Methylcobalamin + Pyridoxine Hydrochloride + Folic Acid is prescribed for the treatment and prevention of:

• Peripheral Neuropathy: This combination is widely used in the management of diabetic neuropathy, alcoholic neuropathy, and drug-induced neuropathy (including chemotherapy-induced peripheral neuropathy). The synergistic action of all three components supports nerve regeneration and myelin repair.
• Hyperhomocysteinemia: The combination effectively reduces elevated homocysteine levels, managing a key risk factor for cardiovascular disease, stroke, and cognitive disorders.
• Megaloblastic Anemia: Provides comprehensive support for red blood cell maturation when anemia results from combined deficiencies of vitamin B12 and folic acid.
• Cognitive Decline and Dementia: Used as adjunctive therapy in age-related cognitive decline, Alzheimer's disease, and vascular dementia where hyperhomocysteinemia is implicated.
• Diabetic Complications: Helps manage diabetic neuropathy and reduce the risk of diabetic retinopathy and nephropathy through homocysteine-lowering and neuroprotective mechanisms.

Why Manufacturers Choose Methylcobalamin + Pyridoxine HCl + Folic Acid

This triple vitamin combination is one of the most widely prescribed neurotrophic formulations in India, with consistent demand from neurologists, diabetologists, and general physicians. The combination addresses the growing burden of diabetic neuropathy in India's diabetic population, which is among the largest in the world. Each tablet contains three well-characterized vitamins with established safety profiles and DMF filings, simplifying regulatory approval. The fixed-dose combination allows for once or twice-daily dosing, improving patient compliance compared to taking three separate vitamin supplements. Indian WHO-GMP certified manufacturers produce millions of tablets annually at highly competitive price points while maintaining stringent quality standards. This makes Methylcobalamin + Pyridoxine HCl + Folic Acid one of the most sought-after neurotrophic formulations for third party manufacturing in India, with strong domestic demand and growing export potential across Asia, Africa, and the Middle East.